Siegfried: Management Changes
Says CEO Dr. Rudolf Hanko: “Michael Hüsler led the Finance department successfully and was instrumental in shaping and supporting our company’s expansion. He made a major personal contribution to Siegfried’s overall success during his tenure. We have found a highly experienced and competent successor to Michael Hüsler in Dr. Reto Suter.”
Likewise with effect from May 1, 2017, the Board of Directors has entrusted Dr. Wolfgang Wienand with the management of the Siegfried Group’s global research and development activities. He will be taking over these duties from Dr. René Imwinkelried and will perform this function in addition to his existing responsibilities as Head Strategy, M&A, Legal, IP and Regulatory Affairs. René Imwinkelried continues to manage the Global Technical Operations department – a role he has held since the beginning of the year.
As per May 1, 2017, the members of the Executive Committee are as follows:
- Dr. Rudolf Hanko, CEO
- Dr. Wolfgang Wienand, Head of Research and Development,
Head Strategy and M&A, Legal, IP, Regulatory Affairs - Dr. René Imwinkelried, Head of Global Operations
- Dr. Reto Suter, CFO
- Marianne Späne, Head Business Development & Sales
- Arnoud Middel, Head Human Re
Most read news
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.